Lomitapide Mesylate

CAS 202914-84-9 3 FDA-DMF suppliersSmall Molecule

Overview

Lomitapide Mesylate is an inhibitor of microsomal triglyceride transfer protein and is used as an adjunct to a low-fat diet and other lipid-lowering treatments for the prevention and chronic management of hyperlipidemia. It reduces levels of cholesterol by limiting the secretion of triglyceride-rich lipoproteins into the bloodstream.

Therapeutic areas

Cardiovascular DiseasesLipid Disorders

Related APIs

Atorvastatin
44 suppliers
Bosentan
40 suppliers
Ticagrelor
35 suppliers
Rosuvastatin
34 suppliers
Chlorthalidone
27 suppliers
Ranolazine
27 suppliers
Carvedilol
26 suppliers
Bempedoic Acid
17 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo